These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4968093)

  • 1. Comparisons between the effects of isoniazid in a single daily dose and in divided daily doses.
    Oka S; Motomiya M; Sato H; Fujimoto M; Suzuki K; Sugi H; Oishi M
    Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):88-90. PubMed ID: 4968093
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of isoniazid activity in the presence of chloroquinum diphosphoricum].
    Havel A; Rosenfeld M
    Arzneimittelforschung; 1970 Sep; 20(9):1167-71. PubMed ID: 4992052
    [No Abstract]   [Full Text] [Related]  

  • 3. Isoniazid prophylaxis in experimental tuberculosis. Comparison of single versus multiple daily doses.
    Bjerkedal T; Palmer CE
    Scand J Respir Dis; 1966; 47(2):131-49. PubMed ID: 4957691
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of different isoniazid concentrations on the Mycobacterium tuberculosis variant highly resistant to the preparation].
    Bondarev IM; Dolgaia TM
    Probl Tuberk; 1980 Aug; (8):65-9. PubMed ID: 6773048
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of treatment of experimental tuberculosis in guinea pigs with isoniazid or with isoniazid combined with ethambutol, either in continous or in intermittent regimen].
    Sosnowski W; Rozniecki J; Tomaszkiewicz L; Bechcińska B; Cyperling I
    Gruzlica; 1970 Jan; 38(1):35-42. PubMed ID: 4984432
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
    Grumbach F; Canetti G; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):312-9. PubMed ID: 4994882
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of tuberculosis in mice using single implants of isoniazid and pyrazinamide.
    Gangadharam PR; Geeta N; Hsu YY; Wise DL
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):515-20. PubMed ID: 10383065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of resistance of Mycobacterium tuberculosis to chemoantibiotics].
    Lucchesi M; Zubiani M; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1967; 27(3):228-52. PubMed ID: 4972422
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results.
    Grumbach F; Canetti G; Le Lirzin M
    Tubercle; 1969 Sep; 50(3):280-93. PubMed ID: 4981497
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of isoniazid on the early tuberculous lesions in the mouse].
    Mauss H
    Rev Immunol Ther Antimicrob; 1968; 32(6):357-74. PubMed ID: 4975681
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of short-course chemotherapy for tuberculosis.
    Grosset J
    Bull Pan Am Health Organ; 1980; 14(2):139-49. PubMed ID: 6774794
    [No Abstract]   [Full Text] [Related]  

  • 13. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
    Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
    J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction to a formal theory of the dosage regimen calculation in intermittent chemotherapy of tuberculosis.
    Bercea O; Bonciocat N
    Arzneimittelforschung; 1970 Feb; 20(2):241-5. PubMed ID: 4986038
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug; 37(954):67-70. PubMed ID: 7616907
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of isoniazid administration on pulmonary tuberculous patients with isoniazid-resistant strain.
    Oka S; Motomiya M; Sato H; Fujimoto M
    Sci Rep Res Inst Tohoku Univ Med; 1967 Nov; 14(3):177-80. PubMed ID: 4978373
    [No Abstract]   [Full Text] [Related]  

  • 17. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2004 Jul; 54(1):266-8. PubMed ID: 15128731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibacterial effectiveness of long-acting isoniazid in the experiment].
    Shkurupií VA; Kurunov IN; Arkhipov SA
    Probl Tuberk; 1997; (2):54-6. PubMed ID: 9235596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
    Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.